These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 23228902

  • 1. Spinal muscular atrophy: going beyond the motor neuron.
    Hamilton G, Gillingwater TH.
    Trends Mol Med; 2013 Jan; 19(1):40-50. PubMed ID: 23228902
    [Abstract] [Full Text] [Related]

  • 2. Stathmin, a microtubule-destabilizing protein, is dysregulated in spinal muscular atrophy.
    Wen HL, Lin YT, Ting CH, Lin-Chao S, Li H, Hsieh-Li HM.
    Hum Mol Genet; 2010 May 01; 19(9):1766-78. PubMed ID: 20176735
    [Abstract] [Full Text] [Related]

  • 3. Tissue-specific models of spinal muscular atrophy confirm a critical role of SMN in motor neurons from embryonic to adult stages.
    Laird AS, Mackovski N, Rinkwitz S, Becker TS, Giacomotto J.
    Hum Mol Genet; 2016 May 01; 25(9):1728-38. PubMed ID: 26908606
    [Abstract] [Full Text] [Related]

  • 4. A new model to study spinal muscular atrophy: neurite degeneration and cell death is counteracted by BCL-X(L) Overexpression in motoneurons.
    Garcera A, Mincheva S, Gou-Fabregas M, Caraballo-Miralles V, Lladó J, Comella JX, Soler RM.
    Neurobiol Dis; 2011 Jun 01; 42(3):415-26. PubMed ID: 21333739
    [Abstract] [Full Text] [Related]

  • 5. Decreased stathmin expression ameliorates neuromuscular defects but fails to prolong survival in a mouse model of spinal muscular atrophy.
    Wen HL, Ting CH, Liu HC, Li H, Lin-Chao S.
    Neurobiol Dis; 2013 Apr 01; 52():94-103. PubMed ID: 23268200
    [Abstract] [Full Text] [Related]

  • 6. Hypothermia improves disease manifestations in SMA mice via SMN augmentation.
    Tsai LK, Chen CL, Tsai YC, Ting CH, Chien YH, Lee NC, Hwu WL.
    Hum Mol Genet; 2016 Feb 15; 25(4):631-41. PubMed ID: 26647309
    [Abstract] [Full Text] [Related]

  • 7. Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
    Nash LA, Burns JK, Chardon JW, Kothary R, Parks RJ.
    Curr Mol Med; 2016 Feb 15; 16(9):779-792. PubMed ID: 27894243
    [Abstract] [Full Text] [Related]

  • 8. Supraphysiological expression of survival motor neuron protein from an adenovirus vector does not adversely affect cell function.
    Goulet BB, McFall ER, Wong CM, Kothary R, Parks RJ.
    Biochem Cell Biol; 2013 Aug 15; 91(4):252-64. PubMed ID: 23859020
    [Abstract] [Full Text] [Related]

  • 9. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.
    Anderton RS, Price LL, Turner BJ, Meloni BP, Mitrpant C, Mastaglia FL, Goh C, Wilton SD, Boulos S.
    Neuroscience; 2012 Sep 18; 220():228-36. PubMed ID: 22732506
    [Abstract] [Full Text] [Related]

  • 10. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
    Monani UR.
    Neuron; 2005 Dec 22; 48(6):885-96. PubMed ID: 16364894
    [Abstract] [Full Text] [Related]

  • 11. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective.
    Blatnik AJ, McGovern VL, Burghes AHM.
    Int J Mol Sci; 2021 Aug 06; 22(16):. PubMed ID: 34445199
    [Abstract] [Full Text] [Related]

  • 12. The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin.
    Nölle A, Zeug A, van Bergeijk J, Tönges L, Gerhard R, Brinkmann H, Al Rayes S, Hensel N, Schill Y, Apkhazava D, Jablonka S, O'mer J, Srivastav RK, Baasner A, Lingor P, Wirth B, Ponimaskin E, Niedenthal R, Grothe C, Claus P.
    Hum Mol Genet; 2011 Dec 15; 20(24):4865-78. PubMed ID: 21920940
    [Abstract] [Full Text] [Related]

  • 13. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy.
    Acsadi G, Lee I, Li X, Khaidakov M, Pecinova A, Parker GC, Hüttemann M.
    J Neurosci Res; 2009 Sep 15; 87(12):2748-56. PubMed ID: 19437551
    [Abstract] [Full Text] [Related]

  • 14. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
    Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P, Carcenac R, Astord S, Pereira de Moura A, Voit T, Barkats M.
    Hum Mol Genet; 2011 Feb 15; 20(4):681-93. PubMed ID: 21118896
    [Abstract] [Full Text] [Related]

  • 15. Therapeutics development for spinal muscular atrophy.
    Sumner CJ.
    NeuroRx; 2006 Apr 15; 3(2):235-45. PubMed ID: 16554261
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
    Liu H, Beauvais A, Baker AN, Tsilfidis C, Kothary R.
    Dev Neurobiol; 2011 Feb 15; 71(2):153-69. PubMed ID: 20862739
    [Abstract] [Full Text] [Related]

  • 19. The Biochemistry of Survival Motor Neuron Protein Is Paving the Way to Novel Therapies for Spinal Muscle Atrophy.
    Lomonte P, Baklouti F, Binda O.
    Biochemistry; 2020 Apr 14; 59(14):1391-1397. PubMed ID: 32227847
    [Abstract] [Full Text] [Related]

  • 20. Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.
    Kim JK, Jha NN, Feng Z, Faleiro MR, Chiriboga CA, Wei-Lapierre L, Dirksen RT, Ko CP, Monani UR.
    J Clin Invest; 2020 Mar 02; 130(3):1271-1287. PubMed ID: 32039917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.